Achira Labs
Achira Labs is a pioneering medical technology company based in Bangalore, India, founded in 2009. It specializes in microfluidics research and development, assay development, and manufacturing of point-of-care diagnostic platforms. The company's mission is to revolutionize point-of-care medical diagnostics by providing rapid, reliable, and lab-quality results using innovative, automated, and multiplexed testing platforms that require only a small volume of blood. Achira's vision is to make advanced medical testing more accessible, bringing sophisticated tests closer to the point of diagnosis, treatment, and management, with a focus on patient-centric innovation.
Industries
Nr. of Employees
small (1-50)
Achira Labs
66b, 13th Cross Rd, Dollar Layout, Bengaluru – 560078, India
Patents
Compositions for fabric based lateral flow assay device using electrochemical detection means, and devices therefrom
US-9714912-B2
View DetailsMethods of making a diagnostic device by interweaving hydrophobic and hydrophilic fibers, and diagnostic device therefrom
US-8709354-B2
View Details
Compositions for fabric based lateral flow assay device using electrochemical detection means, and devices therefrom
US-9714912-B2
View DetailsMethods of making a diagnostic device by interweaving hydrophobic and hydrophilic fibers, and diagnostic device therefrom
US-8709354-B2
View DetailsProducts
ACIX
Automated, multiplexed microfluidic point-of-care platform comprising a portable reader and disposable cartridges containing dry reagents and hydrogel sensors; supports serum and whole-blood samples with rapid (~30 min) turnaround.
USelect
Sperm separation product that combines magnetic-bead based separation with hyaluronic-acid binding to select mature sperm, aiming to reduce DNA fragmentation and oxidative stress markers and improve intrauterine insemination outcomes.
ACIX
Automated, multiplexed microfluidic point-of-care platform comprising a portable reader and disposable cartridges containing dry reagents and hydrogel sensors; supports serum and whole-blood samples with rapid (~30 min) turnaround.
USelect
Sperm separation product that combines magnetic-bead based separation with hyaluronic-acid binding to select mature sperm, aiming to reduce DNA fragmentation and oxidative stress markers and improve intrauterine insemination outcomes.
Services
Collaborative development and porting of established assays onto a cartridge-based point-of-care platform for quantitative, multiplexed testing.
Manufacture of integrated readers and disposable microfluidic cartridges in an ISO 13485-compliant facility with established supply chain pathways.
Commercial collaborations to leverage partner distribution channels and accelerate product launches in domestic and international markets.
Collaborative development and porting of established assays onto a cartridge-based point-of-care platform for quantitative, multiplexed testing.
Manufacture of integrated readers and disposable microfluidic cartridges in an ISO 13485-compliant facility with established supply chain pathways.
Commercial collaborations to leverage partner distribution channels and accelerate product launches in domestic and international markets.
Expertise Areas
- Point-of-care diagnostics development
- Microfluidics engineering
- Assay development and validation
- Medical device manufacturing (ISO 13485)
Key Technologies
- Microfluidics
- Fluorescence optical detection
- Hydrogel-based sensor chemistry
- Multiplexed immunoassays
News & Updates
Cipla's strategic investment aims to develop affordable, innovative medical kits in India, facilitating participation in the PoC diagnostics and antimicrobial resistance space.
Achira Labs received the award from the President of India, Shri Pranab Mukherjee, recognizing its work in indigenous product commercialization.
Achira Labs weaves microfluidics into diagnostics using silk, offering a low-cost, scalable, and accessible platform for medical testing.
A Bangalore-based startup, Achira Labs, has developed silk-based diagnostic test strips by hand weaving, leveraging silk's advantages for affordable and accessible healthcare.
Recognized for its innovation and contribution to indigenous medical diagnostics.
Cipla's strategic investment aims to develop affordable, innovative medical kits in India, facilitating participation in the PoC diagnostics and antimicrobial resistance space.
Achira Labs received the award from the President of India, Shri Pranab Mukherjee, recognizing its work in indigenous product commercialization.
Achira Labs weaves microfluidics into diagnostics using silk, offering a low-cost, scalable, and accessible platform for medical testing.
A Bangalore-based startup, Achira Labs, has developed silk-based diagnostic test strips by hand weaving, leveraging silk's advantages for affordable and accessible healthcare.
Recognized for its innovation and contribution to indigenous medical diagnostics.